SARMs Payment Processing — Visa & Mastercard Acceptance

SARMs Merchant Processing

Why SARMs merchants struggle with payment processing

Selective Androgen Receptor Modulators (SARMs) sit in one of the most challenging categories for payment processing. They're legal to sell for research purposes in most jurisdictions, but card networks and acquiring banks treat them with extreme caution due to regulatory scrutiny and association with the broader performance-enhancement market.

Most SARMs merchants have experienced the frustrating cycle: apply, get approved (maybe), process for a few weeks, get terminated. Or simply get declined from the start. We break that cycle by connecting you with acquirers that have a track record of supporting SARMs merchants long-term.

What We Offer

Stable processing for SARMs businesses

Acquiring bank relationships with active SARMs merchant portfolios
Both domestic (US) and international processing options
Multi-MID strategies to distribute volume and reduce risk concentration
Chargeback prevention tools integrated at the gateway level
3D Secure authentication to shift fraud liability
Transparent pricing with no hidden fees or surprise rate increases

🔀

Multi-MID Load Balancing

Distribute processing volume across multiple merchant IDs to stay well within chargeback thresholds and ensure continuity if any single account faces issues.

🌐

Domestic + Offshore Strategy

We build redundant processing setups with both domestic and offshore acquiring so you're never left without a working payment method.

📋

Compliance Guidance

Advice on website compliance, product labeling, and disclaimer requirements that acquiring banks look for during underwriting.

FAQ

SARMs Processing Questions

Are SARMs legal to process?

SARMs sold for research purposes are legal in most jurisdictions including the US. However, marketing them for human consumption may create regulatory issues. Our acquiring partners require proper "for research use only" labeling and website disclaimers.

What approval rate do you see for SARMs merchants?

SARMs have a lower approval rate than general peptides — roughly 80-85% of applications we submit are approved. The key factors are clean processing history, compliant website, proper business documentation, and appropriate product labeling.

Will my rates be higher than standard peptide processing?

Generally yes — SARMs typically carry a premium of 0.5-1.5% over standard peptide processing rates due to the additional risk classification. Exact pricing depends on your volume, average transaction size, and processing history.

SARMs Payment Processing Solutions